The phenomenon of chemsex has moved from hidden circles into national headlines, yet the health response remains fragmented. Dr Jean-Victor Blanc, a psychiatrist at Saint-Antoine hospital and an educator at Sorbonne University, has spent nearly a decade hearing men describe lives unravelled by sessions that mixed sex and psychoactive substances. He published Des Amours chimiques on April 3, a book that combines clinical cases and research to explain how social pressures, cultural dynamics and individual vulnerabilities converge into a modern public-health problem. In his account, the first casualty of this crisis has often been silence — patients hide, communities avoid, and services struggle to respond.
To frame his observations, Blanc uses the term chemsex as the specific practice of combining sexual activity with stimulant or psychoactive drug use in ways that increase risk and can lead to loss of control. His clinical practice hosts one of the few consultations in France dedicated to this pattern of consumption, exposing both the human cost and the systemic obstacles that prevent timely care. The stories he relays emphasize how media spectacle and moralizing coverage around famous or tragic cases can drive sufferers further into secrecy rather than toward help.
Why silence has been so damaging
Publicity has often focused on scandal rather than health: celebrity names and lurid details attract attention, but they rarely produce constructive health responses. That dynamic reinforces a culture of concealment among men who practice chemsex. At the same time, political indifference grows when a problem is framed as belonging to a minority; when a behaviour mainly affects gay men, it can be deprioritized. Dr Blanc argues that if a comparable trend emerged in a majority population, resources and rapid policy responses would likely follow. This combined neglect—by society and by some within affected communities fearful of reinforcing stereotypes—has allowed harm to multiply.
Barriers to care and community tensions
Political and systemic obstacles
Health services are already strained, and specialized consultations for chemsex are few. Blanc reports that roughly a quarter of those who practice chemsex feel they need professional help; demand exceeds the limited supply of services. Waiting lists are long: even when people reach out in crisis they may face delays of weeks or months, a reality that reflects broader saturation in mental-health care. To illustrate the scale, he notes that wait times for public child mental-health services often average months—an indicator of system-wide under-resourcing that worsens outcomes for adults in distress as well.
Community silence and stigma
Within parts of the gay community there was historically reluctance to discuss links between sexuality and risky drug use. That hesitation was rooted in understandable fear: public alarm could feed homophobic stereotypes and moral panic. Yet the cost of silence has been steep. Many men internalize shame and avoid care; others encounter clinicians who are unprepared or even hostile. Dr Blanc documents patients who tried to raise their experiences with generalist addiction services and were told, in effect, that their needs did not fit. These responses create a vicious circle in which stigma compounds psychological distress and barriers to treatment.
Treatment realities and practical solutions
Addressing the problem requires pragmatic, evidence-based interventions rather than moralizing campaigns. Blanc warns against expecting a single pharmaceutical fix: the problematic use of chemsex involves a strong bio-psycho-social interplay and varies from person to person. Pharmaceutical research faces economic limits too—private drug developers see little commercial incentive to fund costly trials for niche applications. As a result, no specific substitution medication for chemsex exists today, mirroring the lack of approved pharmacotherapies for many stimulants such as cocaine.
What is feasible now is improved training and service design. Two-thirds of patients seen in Blanc’s specialized clinic had previously consulted mental-health professionals but could not discuss their chemsex practices—either because clinicians lacked knowledge, normalized the distress, or expressed homophobic attitudes. Specialized, welcoming services reduce fear of rejection and create pathways into integrated care that combine psychiatric, addiction and sexual-health expertise. Blanc emphasizes that such multidisciplinary teams, backed by institutional support, can make care accessible and humane.
Finally, policy choices matter: targeted funding, professional training and community-centred prevention could shift outcomes. Combating stigma, improving early access, and expanding specialized consultations are practical, evidence-informed steps. Dr Blanc’s experience at a university hospital shows that with commitment and collaboration, services can be built even in settings not originally designed for community-specific work. His message is both a clinical briefing and a call to action: silence has cost lives; knowledge, resources and empathy can save them.